Decoy-20

N/A

Report date: 2025/08/26 16:23:08

Base Information

Drug NameDecoy-20
Drug Alias NameDecoy-20INDP-020
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsToll-like receptor agonists
TargetsToll-like receptor
Therapy Area/IndicationsSolid tumoursMicrosatellite instability-high cancerCarcinoma, Non-Small-Cell Lung +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIndaptus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIndaptus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursMicrosatellite instability-high cancerCarcinoma, Non-Small-Cell Lung +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A